Faculty of Health Sciences, School of Nutrition Sciences, University of Ottawa, Ottawa, Ontario, Canada.
Faculty of Pharmacy, Department of Microbiology and Immunology, Mansoura University, Mansoura, Egypt.
J Appl Microbiol. 2022 Jun;132(6):4452-4465. doi: 10.1111/jam.15550. Epub 2022 Apr 4.
This study aims to isolate probiotic bacteria candidates from various starter cultures and fermented foods and characterize their ability to produce γ-aminobutyric acid (GABA). GABA is a major inhibitory neuromediator of the central and enteric nervous systems with a role in several health disorders.
Fourteen strains of lactic acid bacteria were isolated from food environment and screened for the presence of the glutamate decarboxylase (gadB) gene using PCR and GAD enzymatic assay. The identified potent GABA-producers included Strep. thermophilus, Lactiplantibacillus plantarum and Lact. delbrueckii subsp. bulgaricus. GC-FID analyses confirmed the high GABA production capacity of Strep. thermophilus ST16 (1641.5 ± 154.15 μmol l ), Strep. thermophilus ST8 (1724.5 ± 48.08 μmol/L). To a lesser extent, Bif. animalis ST20, Lact. acidophilus LP16-2 and Ent. faecium ST3 produced 947.5 ± 70.71, 918.0 ± 121.42, and 907.83 ± 55.15 μmol/L of GABA, respectively. These potent strains were able to grow and produce GABA in MRS broth and pre-fermented Macfarlane broth, the latter medium mimicking the nutrient and metabolome composition encountered in the colon. The identified bioactive strains exhibited strong biological safety and probiotic potential profiles as indicated by sensitivity to antibiotics, absence of virulence factors and survival in gastrointestinal conditions.
Several GABA producing probiotic candidates, including Bif. animals ST20, Strep. thermophilus ST8, Lact. acidophilus LP16-2, L. plantarum LP6 & LP9, and Ent. faecium ST3, have shown potential to grow under simulated colonic conditions.
Findings from this study provide evidence of the suitability of the isolated GABA-producing probiotic candidates for the development of health-oriented functional food products.
本研究旨在从各种发酵剂和发酵食品中分离出益生菌候选株,并对其产生γ-氨基丁酸(GABA)的能力进行表征。GABA 是中枢和肠神经系统的主要抑制性神经递质,在多种健康疾病中发挥作用。
从食品环境中分离出 14 株乳酸菌,采用 PCR 和 GAD 酶分析法筛选谷氨酸脱羧酶(gadB)基因的存在。鉴定出的强效 GABA 产生菌包括嗜热链球菌、植物乳杆菌和德氏乳杆菌保加利亚亚种。GC-FID 分析证实,嗜热链球菌 ST16(1641.5±154.15μmol·l-1)和 ST8(1724.5±48.08μmol/L)具有很高的 GABA 生产能力。双歧杆菌 ST20、嗜酸乳杆菌 LP16-2 和粪肠球菌 ST3 产生的 GABA 分别为 947.5±70.71、918.0±121.42 和 907.83±55.15μmol/L。这些强生产菌株能够在 MRS 肉汤和预发酵的 Macfarlane 肉汤中生长并产生 GABA,后者培养基模拟了结肠中遇到的营养成分和代谢组组成。鉴定出的生物活性菌株具有较强的生物安全性和益生菌潜力,表现为对抗生素的敏感性、无毒力因子和在胃肠道条件下的存活能力。
包括双歧杆菌 ST20、嗜热链球菌 ST8、嗜酸乳杆菌 LP16-2、植物乳杆菌 LP6 和 LP9 以及粪肠球菌 ST3 在内的几种产生 GABA 的益生菌候选株具有在模拟结肠条件下生长的潜力。
本研究结果为分离出的产生 GABA 的益生菌候选株用于开发面向健康的功能性食品产品提供了证据。